drugset / Trial / NCT00757978

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

NCT00757978

Phase 4 Completed 22 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Memantine as an add-on therapy to clozapine may improve schizophrenia negative symptoms and cognitive functioning.

Timeline

Start
2006-01
Primary completion
2008-01
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 10 mg

Indications